您的位置: 首页 > 2024年5月 第55卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

星状神经节阻滞联合银杏叶提取物治疗颈源性头晕的临床研究

Clinical study of stellate ganglia block combined with Ginkgo biloba extract for the treatment of cervical dizziness

来源期刊: 广州医药 | 519-523 发布时间:2024-06-28 收稿时间:2025/11/17 15:49:33 阅读量:8
作者:
关键词:
星状神经节阻滞银杏叶提取物颈源性头晕疾病症状颈部疼痛不良反应
stellate ganglion blockGinkgo biloba extractcervical dizzinessdisease symptomsneck painadverse reactions
DOI:
10.3969/j.issn.1000-8535.2024.05.010
收稿时间:
2023-07-16 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 研究并分析星状神经节阻滞联合银杏叶提取物治疗颈源性头晕的临床效果。方法 选取周口骨科医院100例颈源性头晕的住院患者作为研究对象,于2022年6月—2023年6月期间内收治,根据入院顺序奇偶号将其分为对照组与观察组,各50例,对照组实行星状神经节阻滞治疗,观察组在对照组基础上联合使用银杏叶提取物治疗,对比两组患者的临床症状(头痛、眩晕、耳鸣、视物模糊)改善程度、颈部疼痛量表、临床效果和不良反应发生率。结果 治疗30 d后,观察组临床症状评分低于对照组(P<0.05)。两组治疗前的数字分级法评分差异无统计学意义(P>0.05),治疗15 d与30 d时,观察组数字分级法评分评分均低于对照组(P<0.05)。观察组患者的治疗总有效率高于对照组(P<0.05);治疗期间,观察组的并发症发生率低于对照组,比较差异有统计学意义(P<0.05)。结论 颈源性头晕患者使用星状神经节阻滞联合银杏叶提取物治疗,能够明显改善疾病症状,缓解颈部疼痛感,有效提高临床效果,同时降低不良反应发生率。
Objective To analyze the clinical study of stellate ganglion block combined with Ginkgo biloba extract to treat cervical dizziness.Methods A total of 100 hospitalized patients with cervical dizziness at Zhoukou Orthopedic Hospital were selected as the study subjects,who were admitted between June 2022 and June 2023.They were divided into a control group and an observation group based on the odd and even numbers of admission,with 50 cases in each group.The control group received stellate ganglion block treatment,while the observation group received a combination of Ginkgo biloba extract treatment on the basis of the control group,The degree of improvement in clinical symptoms(headache,dizziness,tinnitus,blurred vision),neck pain scale,clinical efficacy,and incidence of adverse reactions were compared between two groups of patients.Results After 30 days of treatment,the clinical symptom score of the observation group was lower than that of the control group(P<0.05).There was no statistically significant difference in the numerical grading scores between the two groups before treatment(P>0.05).On the 15th and 30th day of treatment,the observation group had lower numerical grading scores than the control group(P<0.05).The total effective rate of treatment in the observation group was higher than that in the control group(P<0.05).During the treatment period,the incidence of complications in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusions The use of stellate ganglion block combined with Ginkgo biloba extract in the treatment of patients with cervicogenic dizziness can significantly improve their disease symptoms,significantly alleviate their neck pain,effectively improve the clinical effect,while reducing the incidence of adverse reactions.
1、 曹洋. 头针配合颈夹脊治疗颈源性眩晕的临床研究[D].长春:长春中医药大学,2022. 曹洋. 头针配合颈夹脊治疗颈源性眩晕的临床研究[D].长春:长春中医药大学,2022.
2、 黄伟. 颈2背根神经节脉冲射频治疗颈源性头晕临床疗效观察[J].航空航天医学杂志,2020,31(1):42-44. 黄伟. 颈2背根神经节脉冲射频治疗颈源性头晕临床疗效观察[J].航空航天医学杂志,2020,31(1):42-44.
3、 都红美. 针刺项五针配中药治疗颈源性眩晕的疗效观察[J].医学食疗与健康,2021,19(8):28-29. 都红美. 针刺项五针配中药治疗颈源性眩晕的疗效观察[J].医学食疗与健康,2021,19(8):28-29.
4、 蔡建辉,吴振华,夏文辉,等.电针双侧晕听区配合甲磺酸倍他司汀片治疗颈源性眩晕疗效观察[J].中国中医急症,2023,32(5):873-876. 蔡建辉,吴振华,夏文辉,等.电针双侧晕听区配合甲磺酸倍他司汀片治疗颈源性眩晕疗效观察[J].中国中医急症,2023,32(5):873-876.
5、 姚琦,潘晓峰,潘宋斌,等.金纳多治疗良性阵发性位置性眩晕复位成功后残余头晕症状的疗效评估[J].中华耳科学杂志,2020,18(5):897-901. 姚琦,潘晓峰,潘宋斌,等.金纳多治疗良性阵发性位置性眩晕复位成功后残余头晕症状的疗效评估[J].中华耳科学杂志,2020,18(5):897-901.
6、 任树军,杨春雨,杜海月,等.浮针配合颈舒颗粒治疗颈源性眩晕临床研究[J].中国中医急症,2021,30(5):813-815,838. 任树军,杨春雨,杜海月,等.浮针配合颈舒颗粒治疗颈源性眩晕临床研究[J].中国中医急症,2021,30(5):813-815,838.
7、 谭伟杰,董俊球,贺丹.胸锁乳突肌触发点针刺联合背俞穴温针灸治疗颈源性眩晕气血亏虚证临床研究[J].中医药导报,2022,28(8):81-85. 谭伟杰,董俊球,贺丹.胸锁乳突肌触发点针刺联合背俞穴温针灸治疗颈源性眩晕气血亏虚证临床研究[J].中医药导报,2022,28(8):81-85.
8、 贺乾,王玉巍,安丹.数字疼痛分级法对腹股沟疝无张力修补术后患者镇痛的影响[J].中华疝和腹壁外科杂志(电子版),2021,15(2):191-194. 贺乾,王玉巍,安丹.数字疼痛分级法对腹股沟疝无张力修补术后患者镇痛的影响[J].中华疝和腹壁外科杂志(电子版),2021,15(2):191-194.
9、 曹洪欣. 《中医循证临床实践指南》[J].中国标准化(英文版),2015(4):102-105. 曹洪欣. 《中医循证临床实践指南》[J].中国标准化(英文版),2015(4):102-105.
10、 XIAO H,PENG B,MA K,et al.The Chinese association for the study of pain(CASP):Expert consensus on the cervicogenic headache[J].Pain Res Manag,2019(2019):9617280. XIAO H,PENG B,MA K,et al.The Chinese association for the study of pain(CASP):Expert consensus on the cervicogenic headache[J].Pain Res Manag,2019(2019):9617280.
11、 覃启才,吴忠强,姚志源,等.SRM-IV良性阵发性位置性眩晕诊疗系统联合金纳多对良性阵发性位置性眩晕复位后残余头晕的疗效研究[J].微创医学,2022,17(3):339-341,358. 覃启才,吴忠强,姚志源,等.SRM-IV良性阵发性位置性眩晕诊疗系统联合金纳多对良性阵发性位置性眩晕复位后残余头晕的疗效研究[J].微创医学,2022,17(3):339-341,358.
12、 彭丽莉. 头部穴位放血在风阳上扰证颈源性眩晕患者中的应用及效果研究[J].保健文汇,2023,24(13):221-224. 彭丽莉. 头部穴位放血在风阳上扰证颈源性眩晕患者中的应用及效果研究[J].保健文汇,2023,24(13):221-224.
13、 何秋茂,林嘉杰,赵家友,等.中医推拿治疗颈源性头晕头痛的脑内信息响应特征研究[J].按摩与康复医学,2019,10(21):19-21,24. 何秋茂,林嘉杰,赵家友,等.中医推拿治疗颈源性头晕头痛的脑内信息响应特征研究[J].按摩与康复医学,2019,10(21):19-21,24.
14、 辛荣超,李宜,党建军,等.颈源性眩晕病变节段发病率及压痛点分布的临床研究[J].山西医药杂志,2020,49(23):3223-3225. 辛荣超,李宜,党建军,等.颈源性眩晕病变节段发病率及压痛点分布的临床研究[J].山西医药杂志,2020,49(23):3223-3225.
15、 庞晓东,吴兵,高春华,等.颈椎间盘源性头晕发病机制研究进展[J].中华疼痛学杂志,2022(5):707-711. 庞晓东,吴兵,高春华,等.颈椎间盘源性头晕发病机制研究进展[J].中华疼痛学杂志,2022(5):707-711.
1、朱红梅,习明明,顾琴,等.直线偏振光治疗仪照射星状神经节对颈源性头晕患者的影响[J].医疗装备,2025,38(05):75-78. 朱红梅,习明明,顾琴,等.直线偏振光治疗仪照射星状神经节对颈源性头晕患者的影响[J].医疗装备,2025,38(05):75-78.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录